Company intelligence / Profile preview
Marinomed Biotech
Korneuburg, Lower Austria, Austriamarinomed.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Marinomed has successfully developed and marketed Carragelose-based OTC products for viral respiratory infections, now outlicensed globally. Its Marinosolv platform has enabled late-stage clinical candidates such as Budesolv for allergic rhinitis, which met all endpoints in a Phase III trial. The pipeline includes additional immunology and ophthalmology assets leveraging Marinosolv technology.
- Therapeutic areas
- OphthalmologyImmunologyInfectious Diseases
- Modalities
- Small moleculeProteinPolymerCorticosteroidImmunosuppressantMedical device
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Unither Pharmaceuticals – acquired the Carragelose business in February 2025 with ongoing collaboration on product commercialization.Numerous global pharmaceutical partners have licensed or distributed Carragelose-based products (>40 countries).Swiss pharma partner signed term sheet for Budesolv commercialization.
Beyond the preview
Go deeper on Marinomed Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Marinomed Biotech.